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Abstract: Purinergic signals, such as extracellular adenosine triphosphate (ATP) and adenosine
diphosphate (ADP), mediate intercellular communication and stress responses throughout mammalian
tissues, but the dynamics of their release and clearance are still not well understood. Although
physiochemical methods provide important insight into physiology, genetically encoded optical
sensors have proven particularly powerful in the quantification of signaling in live specimens. Indeed,
genetically encoded luminescent and fluorescent sensors provide new insights into ATP-mediated
purinergic signaling. However, new tools to detect extracellular ADP are still required. To this end,
in this study, we use protein engineering to generate a new genetically encoded sensor that employs
a high-affinity bacterial ADP-binding protein and reports a change in occupancy with a change in
the Förster-type resonance energy transfer (FRET) between cyan and yellow fluorescent proteins.
We characterize the sensor in both protein solution studies, as well as live-cell microscopy. This
new sensor responds to nanomolar and micromolar concentrations of ADP and ATP in solution,
respectively, and in principle it is the first fully-genetically encoded sensor with sufficiently high
affinity for ADP to detect low levels of extracellular ADP. Furthermore, we demonstrate that tethering
the sensor to the cell surface enables the detection of physiologically relevant nucleotide release
induced by hypoosmotic shock as a model of tissue edema. Thus, we provide a new tool to study
purinergic signaling that can be used across genetically tractable model systems.
Keywords: extracellular ADP; purinergic signaling; fluorescent sensor; FRET; genetically encoded
1. Introduction
Purinergic signaling regulates a broad range of critical physiological processes such as neuron-glia
communication, immune cell responses, and platelet aggregation, and may be a key determinant of
disease states such as cancer [1–6]. In injuries that result in tissue edema, purinergic signaling also
plays an important role in the cell volume regulatory response to changes in osmotic pressure [1,6–12].
In purinergic signaling, extracellular adenosine triphosphate (ATP) is a ligand of P2X ion channels
and several P2Y G-protein coupled receptors, and extracellular adenosine diphosphate (ADP) can
also activate several P2Y receptors [1–6]. As such, there is a need for sensitive detection methods
to measure the release and clearance of extracellular nucleotides such as ATP and ADP, as well as
adenosine in order to understand the stress response. We recently developed a genetically-encoded
fluorescent sensor of extracellular ATP [13], but there has not been a genetically encoded fluorescent
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sensor of ADP until now. One major challenge to the development of these purinergic sensors is that
extracellular nucleotides signal at low concentrations, putatively at hundreds of nanomolar to low
micromolar levels [14]. Here, we take advantage of a bacterial protein that has a high affinity for ADP,
called ParM, and use it to engineer an extracellular ADP sensor successfully.
ParM is an actin-like Escherichia coli (E. coli) protein that exhibits a large conformational change
upon binding ADP (Figure 1) [15]. Previously, Kunzelmann and Webb demonstrated that ParM could
be used to generate a semisynthetic ADP sensor through a structure-guided cysteine mutagenesis
and dye conjugation strategy [16,17]. Their work provides excellent proof that ParM is a fruitful
scaffold for rational sensor design. However, because we are ultimately interested in developing an
extracellular ADP sensor capable of cell type-specific surface display, we asked whether ParM could
also be used to engineer a fluorescent protein-based genetically encoded sensor. Despite the clear
precedent established by Kunzelmann and Webb, the dramatic size difference between fluorescent
proteins and the small organic dyes used previously [16,17] left the answer to this question uncertain.
Here, we now report the successful development of a genetically encoded ParM-based sensor that
reports fluctuations in physiological levels of extracellular ADP through changes in Förster-type
resonance energy transfer (FRET) between a cyan fluorescent protein (CFP) and a yellow fluorescent
protein (YFP).
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Figure 1. Adenosine diphosphate (ADP) sensor designs. (a) The X-ray crystal structures of E. coli ParM 
in the apo (PDB 1MWK) and ADP-bound (1MWM) states illustrate the ADP-dependent 
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loops, which are indicated in (a) by the residues shown as cyan and yellow spheres. A decrease in 
donor-acceptor distance upon ADP-binding would be expected to increase FRET. (c) In the  
“terminal-fusion” sensor design, the fluorescent proteins are fused to the N- and C-termini of ParM. 
The termini are in close proximity to one another, and therefore, an ADP-dependent change in the 
relative orientation between the donor and acceptor would be expected to be the primary cause for a 
change in FRET. 
Figure 1. Adenosine diphosphate (ADP) sensor designs. (a) The X-ray crystal structures of E. coli Par
in the apo (PDB 1MWK) and ADP-bound (1MWM) states illustrate the ADP-dependent conformational
change. (b) In the “insertion-fusion” sensor design, the cyan (mTFP) and yellow (mVenus) fluorescent
proteins are inserted within the ParM protein at the apical surface-exposed loops, which are indicated
in (a) by the residues shown as cyan and yellow spheres. A decrease in donor-acceptor distance upon
ADP-binding would be expected to increase FRET. (c) In the “terminal-fusion” sensor design, the
fluorescent proteins are fused to the N- and C-termini of ParM. The termini are in close proximity to
one another, and therefore, an ADP-dependent change in the relative orientation between the donor
and acceptor would be expected to be the primary cause for a change in FRET.
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2. Materials and Methods
Chemicals. Unless otherwise noted, all chemicals and cell culture reagents were from
Sigma-Aldrich and Thermo Fisher Scientific. Synthetic gBlock DNA and oligonucleotides were
from Integrated DNA Technologies.
Protein Engineering and Library Screening. The E. coli ParM gene was synthesized as a gBlock
and subcloned into the pRSETB bacterial expression vector. The genes for the mTFP1 and mVenus
wildtype and circularly permuted variants were subcloned from the Pertz Lab cpFRET biosensors
kit (Addgene kit # 1000000021) [18]. The fusions between ParM and the fluorescent proteins were
generated using the NotI and BspEI restriction enzyme sites engineered in the Pertz kit gene constructs,
using PCR mutagenesis to create appropriate restriction sites in the ParM gene. Standard restriction
enzyme, PCR mutagenesis, and Gibson Assembly (NEB HiFi Kit) approaches were used to generate
linker libraries.
Individual plasmids or plasmid libraries were transformed into DH5α E. coli and grown in Luria
Broth media shaking at 37 ◦C overnight followed by two additional days of shaking at ambient
temperature. Leaky expression was sufficient for library screening and protein purification. For library
screening, 96-well deep-well plates were inoculated with a single colony per well and grown as
described. Bacterial cultures were then washed and diluted to an OD600 of 0.2 with minimal M9 media
(50 mM Na2HPO4, 20 mM KH2PO4, 20 mM NH4Cl, 9 mM NaCl, 2 mM MgSO4, 0.1 mM CaCl2, pH 7.5).
Steady-state fluorescence emission spectra were measured on a BioTek Synergy H4 Multimode Plate
Reader using 450 nm excitation with a 9 nm bandwidth. The emission ratio was calculated as the
mTFP1 peak emission band intensity at 495 nm divided by the mVenus sensitized FRET emission
intensity at 525 nm, both with 9 nm bandwidths. After the baseline spectra were measured, KCN was
added to a final concentration of 10 mM [19], and cells were incubated for 10 min to allow for the
depletion of ATP and accumulation of ADP before a second set of spectra were measured.
For time-resolved spectroscopy, fluorescence lifetime decays were measured using time-correlated
single-photon counting on an Edinburgh Instrument FS5+ spectrometer with a NKT Photonics Fianium
WhiteLaseMicro pulsed laser source. Live E. coli suspensions were prepared as described above
except that cultures were diluted to an OD600 of ~0.5 and pre-starved for 30–60 min in the absence of
glucose. Live-cell lifetime decays were collected using Fluoracle software, and empirical lifetimes were
measured and analyzed in Matlab as previously described [20].
In vitro characterization. Sensor protein was expressed in DH5αE. coli, grown in Luria Broth media
shaking at 37 ◦C overnight followed by two additional days of shaking at ambient temperature. Cells
were lysed and purified using nickel affinity chromatography on a HiTrapTM Chelating HP column.
The purified protein was dialyzed to remove excess concentrations of imidazole. The dose-response
assays were performed with a BioTek Synergy H4 Multimode Plate Reader at a protein concentration
of 0.125 µM in assay buffer (50 mM MOPS-KOH, 50 mM KCl, 0.5 mM MgCl2, 0.05% Triton-X, pH 7.3).
ADP and ATP were complexed with magnesium prior to use in the dose-response assays. Nucleotide
concentration was confirmed via absorbance measurements. The Origin software package was used to
fit the dose-response data and calculate the Kd using the Hill function.
Live-cell microscopy. The sensor gene used for soluble expression was subcloned into the
pCMV(MinDis) mammalian cell-surface expression vector, in which the sensor was tethered to
the outer face of the plasma membrane by the platelet-derived growth factor receptor (PDGFR)
transmembrane domain and an Igκ secretion signal, obtained from the iGluSnFR developed by the
Looger Group [21]. HEK293A cells were plated on nitric acid cleaned glass coverslips and transfected
by the calcium phosphate method. The coverslips were placed in a Warner superfusion chamber with
a continuous flow of imaging solution (120 mM NaCl, 15 mM HEPES, 10 mM glucose, 3 mM KCl,
3 mM NaHCO3, 2 mM CaCl2, 1.25 mM NaH2PO4, 1 mM MgCl2, pH 7.3) at ~2 mL/min at ambient
temperature. The cells were equilibrated in the chamber for a minimum of 15 min prior to imaging. For
live-cell dose-response experiments, ADP and ATP were diluted in imaging solution to the appropriate
final concentration. For hypoosmotic shock, an imaging solution containing a reduced concentration of
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60 mM NaCl was used. Images were collected on an Olympus IX83 microscope with an Andor Zyla 4.2
sCMOS camera set at 2-by-2 pixel binning and 100 millisecond-exposure times and using 20X 0.75 NA
PlanApo air objective. Images were collected at a 10 s interval using a Lumencor SpectraX as an
excitation source of 438 nm and 470 nm excitation and emission filters to collect CFP donor fluorescence,
438 nm and 540 nm filters to collect CFP-YFP FRET emission, and 510 nm and 540 nm filters to
collect YFP acceptor fluorescence, respectively. NIH ImageJ software was used for ratiometric image
analysis. Binary masks were generated by using a minimum threshold of the mean plus three standard
deviations of the background intensity. The binary mask was applied to the background-subtracted
images for each channel, and a CFP/FRET pixel-by-pixel ratio image was calculated. The membrane
regions of interest (ROIs) were manually drawn for each cell, and the ratio changes over time were
normalized to a linear baseline.
3. Results
Our objective was to engineer a high affinity genetically encoded sensor of extracellular ADP by
fusing a CFP and YFP FRET pair to the E. coli ParM protein. To do so, we first developed a live-cell
assay to screen soluble candidate sensor libraries. After screening several libraries, we identified a
viable sensor and characterized its performance in solution studies. Finally, we then generated a sensor
construct targeted to the cell surface and validated that this new sensor detects the physiologically
relevant release of extracellular nucleotides.
3.1. Protein Engineering and Library Screening
In our initial designs of the sensor, we explored two possible FRET-based architectures that
differed in the positioning of the CFP-YFP FRET pair when fused to the ParM protein in order to take
advantage of alternative aspects of the ADP-dependent structural change. Upon binding ADP, the
ParM protein undergoes a hinge-like conformational change in which the two domains move closer to
one another (Figure 1) [15]. In our first design, we sought to primarily exploit the distance-dependence
of FRET by fusing the CFP and YFP to opposing sites on the two different ParM domains (Figure 1).
Previously, Kunzelmann and Webb conjugated a coumarin dye to the I27 cysteine mutation site that
experiences a change in solvent exposure upon ADP binding [17], as well as rhodamine dyes to
the D63 and D224 cysteine mutation sites that come in close enough proximity to enable dye-dye
interactions [16]. However, we sought alternative sites to fuse the CFP and YFP because we were
concerned that the ParM structure would not accommodate the large bulk of a fluorescent protein,
especially at the I27 and D224 sites lining the ADP binding site [15]. Instead, we selected CFP and YFP
insertion sites at D41 and D241 because the distance between these two residues decreases by nearly
20 Å upon ADP binding, and they are found on apical surface loops on each respective domain, which
we hypothesized would better tolerate the fusion of large fluorescent proteins (Figure 1).
In our second design, we directly fused the CFP and YFP to the N- and C-termini of the ParM
protein (Figure 1). Although the ParM termini are located close to one another in spatial proximity,
previous work developing a glucose sensor has demonstrated that this is a viable strategy for generating
FRET sensors [22]. In this strategy, we sought to exploit the sensitivity of FRET to the orientation
between the donor and acceptor, hypothesizing that the allostery of ParM would be transduced into a
change in the relative dipole-dipole angle between the CFP and YFP fused to the termini.
For both sensor designs we used ParM harboring select mutations that include: the K33A mutation
which prevents ParM polymerization; the T174A and T175N mutations which reduce ATP affinity
and increase ADP selectivity; and the C287A mutation to remove a surface-exposed cysteine as a
conservative precaution against unwanted redox reactions with the protein [15–17]. The K33A mutation
was also demonstrated to abrogate the ATP hydrolysis activity in two different constructs [16,17].
FRET is dependent on both distance and relative orientation between the CFP donor and YFP
acceptor; therefore, we generated libraries for both the “insertion-fusion” and the “terminal-fusion”
designs using the “cpFRET” biosensor construction kit developed by the Pertz Lab [18]. This kit
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utilizes the cyan mTFP1 [23] as the donor and the yellow mVenus as the acceptor [24]. In addition to
the wildtype versions of these fluorescent proteins, Pertz and co-workers constructed four circular
permutation variants of each, in which the N- and C-termini are relocated to different locations in
the β-barrel structure [18]. For example, in the mTFP1-cp105 circular permutation variant, the native
termini have been fused with a short peptide linker, and new termini are generated at residue 105.
Because of the different termini locations, these circular permutation variants enabled us to generate
combinatorial libraries to screen for an mTFP1-mVenus pair with the optimal orientation for an
ADP-dependent FRET change when fused to ParM (Figure 2a).
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fluorescent TP sensors have demonstrated that cyanide treatment causes a decrease in bacterial ATP
levels [19]. We validated that cyanide caused a decrease in ATP in our assay using the ATeam1.03 ATP
sensor [25], which we also used as an assay control in our screens (Figure 3). Furthermore, we used
a luciferase-based biochemical assay to confirm that cyanide treat ent causes a four-fold increase
in bacterial ADP levels (Figure S1), thus providing the basis for our screen. To screen our libraries,
steady-state fluorescence emission spectra were taken on the live-cell suspensions before and after
cyanide treatment. As our selection criteria, candidate sensor hits were chosen if they exhibited peaks
for both the donor mTFP1 fluorescence and sensitized emission from mVenus, as well as a ratiometric
change in the fluorescence e ission spectra after metabolic inhibition. Note that throughout this
manuscript, we use the “C/Y FRET Ratio” equal to the mTFP1 donor emission intensity divided by
the mVenus-sensitized acceptor FRET emission intensity because the final selected sensor exhibits
a decrease in FRET upon ADP binding, which is a convention used for other FRET sensors [26].
In Figure 3, we quantify the spectral changes as the “Fold Ratio Change” equal to the C/Y FRET Ratio
before treatment divided by the C/Y FRET Ratio after metabolic inhibition. Thus, a Fold Ratio Change
greater than one indicates a decrease in FRET upon ADP binding, whereas a Fold Ratio Change less
than one indicates an increase in FRET upon ADP binding. For example, the control ATeam1.03 ATP
sensor exhibits an increase in FRET upon ATP binding. Hence, metabolic inhibition causes a decrease
in ATP and a decrease in ATeam1.03 FRET, and control samples in Figure 3 (blue squares) exhibit a
Ratio Fold Change greater than one.
espite the large ADP-dependent decrease in distance between insertion sites, the insertion-fusion
library only yielded two candidate hits (Figure 3a). Several of the other clones exhibited large
fluorescence changes but were rejected as false positives because their responses did not meet our
aforementioned criteria, such as a lack of a clear ratiometric spectral change upon closer inspection.
In contrast, eight candidate hits were selected from the terminal-fusion library that exhibited ratiometric
responses. Interestingly, of the total ten candidate hits from our library screens, there was a diversity
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of wildtype and circularly permuted mTFP1 and mVenus pairings without a clear pattern (Table 1).
There was also a diversity of ratiometric spectral changes in which some clones exhibited an increase
in FRET upon metabolic inhibition (Ratio Fold Change < 1) while other clones exhibited a decrease in
FRET upon metabolic inhibition (Ratio Fold Change > 1) (Figure 3).
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Figure 3. Library screening results. Results are shown for the (a) insertion-fusion, (b) terminal-fusion,
(c) linker length, and (d) polyproline linker composition library screens. The y-axis values represent the
fold change in the mTFP1/mVenus FRET ratio after KCN addition relative to baseline measurements
for live-cell suspensions. Each symbol represents the result for a culture grown from a single clone in
the library, and the responses of individual clones are plotted along the x-axis according to Clone #.
The blue squares represent the response of the ATeam1.03 ATP sensor as a control. The red diamonds
represent “hits” in which a response was both ratiometric and could be reproduced, except in (d) where
the red diamond represents the response of the best hit from the library in (c) as a control.
Table 1. The fluorescent protein variants for example library screen “hits”.
Hit ID mTFP1 Variant mVenus Variant
Insertion Clone 1 WT cp157
Insertion Clone 2 cp227 cp157
Terminal Clone 1 cp105 cp173
Terminal Clone 2 WT cp157
Terminal Clone 3 WT cp173
Terminal Clone 4 cp159 WT
Terminal Clone 5 WT cp195
Terminal Clone 6 cp227 WT
Terminal Clone 7 cp227 cp195
Terminal Clone 8 cp227 cp173
As the second stage of optimization, we next varied the length of the linkers that served to attach
the fluorescent proteins to ParM (Figure 3c). We mutagenized the linkers to lengths of three, five,
or seven amino acids in length on each end of both fluorescent proteins and carried out additional
library screens. Again, we observed diverse responses to cyanide treatment, and we selected three top
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candidate hits for re-confirmation. To our surprise, upon sequencing these hits we discovered that all
three represented the same sensor clone, providing unexpected internal validation for the selection of
this sensor, and there was a clear ADP-dependent ratiometric change in its spectra (Figure 4a). This
hit was the terminal-fusion construct that utilized the wildtype mTFP1 connected by a five amino
acid length linker (SGITS) to the N-terminus of ParM, and the mVenus-cp157 variant connected by a
three amino acid length linker (AAA) to the C-terminus of ParM. Here, the compositions of the linkers
were dictated by the cloning strategy. Given that this sensor was derived from the terminal fusion
library, we suspected that the primary cause for the FRET response is that ADP binding to ParM is
transduced as a change in relative orientation between the two fluorescent proteins. As such, we
carried out the third stage of optimization focused on the orientation of the fluorescent proteins in the
sensor. Previously, Thestrup et al. screened polyproline linkers to vary and optimize the orientation of
the fluorescent proteins in the Twitch calcium sensors [27]. We generated a similar polyproline linker
composition library, but we did not identify any significantly improved variants compared to the hit
from the linker length screen (Figure 3d). Therefore, we chose to carry out further characterization on
our new ADP sensor.
3.2. Validation with Live-Cell Time-Resolved Spectroscopy
Upon addition of cyanide to live-cell cultures, the sensor reproducibly reports an increase in
bacterial ADP levels with an increase in the donor mTFP1 emission peak and a reciprocal decrease
in the mVenus sensitized emission peak (Figure 4a). To validate that the observed spectral change
represents a change in FRET, we carried out time-resolved spectroscopy on live-cell cultures expressing
the sensor [20]. From the spectral response, ADP-binding to the sensor causes a decrease in FRET,
which should manifest as an increase in the mTFP1 donor fluorescence lifetime when ADP levels
increase [28]. We also sought to validate that the sensor provides a reversible response, and therefore,
in this assay, we pre-starved the E. coli in M9 minimal media without any amino acids or glucose to
deplete ATP and increase ADP levels. At baseline in the starved state, the donor lifetime of the sensor
is 2.24 ± 0.02 ns (mean ± 95% confidence interval (CI), n = 6). The addition of glucose to the cells
causes consumption of ADP, which was reported by a decrease in the donor lifetime to 2.06 ± 0.02 ns
(mean ± 95% CI, n = 6). The subsequent addition of cyanide caused a reversal, and the donor lifetime
returned to a value of 2.27 ± 0.02 ns (mean ± 95% CI, n = 6) with the increased bacterial ADP levels.
Thus, by using live-cell time-resolved spectroscopy, we validated that our newly identified sensor hit
responds reversibly to fluctuations in ADP concentration with dynamic changes in FRET.Sensors 2019, 19, x FOR PEER REVIEW 8 of 15 
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solution studies. The ADP dose-response of the sensor showed a high affinity with an apparent Kd 
equal to 0.16 ± 0.06 µM (mean ± std, n = 9), which is similar to the previously reported value of  
~0.5 µM for the core ParM protein (Figure 5) [17]. Notably, this high affinity is well-matched to the 
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observed a loss in the dynamic range compared to the live-cell assays, with a maximum FRET ratio 
change of 8%–10%. The difference in the dynamic range could be due to the difference in the crowded 
cellular environment versus dilute solutions, but the exact causes are unknown. We were 
encouraged, however, by the clear usefulness of other recent ratiometric FRET sensors with low 
dynamic ranges [26,29,30], and therefore, we proceeded with further characterization and  
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3.3. Protein Solution Characterization
We next expressed and purified the ADP sensor in order to characterize its performance in solution
studies. The ADP dose-response of the sensor showed a high affinity with an apparent Kd equal
to 0.16 ± 0.06 µM (mean ± std, n = 9), which is similar to the previously reported value of ~0.5 µM
for the core ParM protein (Figure 5) [17]. Notably, this high affinity is well-matched to the putative
nanomolar to micromolar concentration range for extracellular nucleotides. We also observed a loss in
the dynamic range compared to the live-cell assays, with a maximum FRET ratio change of 8%–10%.
The difference in the dynamic range could be due to the difference in the crowded cellular environment
versus dilute solutions, but the exact causes are unknown. We were encouraged, however, by the clear
usefulness of other recent ratiometric FRET sensors with low dynamic ranges [26,29,30], and therefore,
we proceeded with further characterization and proof-of-concept studies.
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Figure 5. ADP affinity. The ADP dose response of the sensor was measured using purified protein in
solution with an apparent Kd = 0.16 ± 0.06 µM (mean ± std, n = 9).
The ParM protein, with its T174A and T175N mutations, has a reduced affinity for ATP as a
competitive ligand, and we directly assessed the ATP binding to our sensor. The ATP dose-response
revealed that the sensor exhibits a significantly lower affinity for ATP with an apparent Kd equal
to 9.9 ± 6.3 µM (mean ± std, n = 3) (Figure 6a). Our sensor, thus, has a much higher affinity for
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ATP compared to the parent ParM protein (Kd ~200 µM [17]), but it still maintains a nearly 62-fold
selectivity for ADP over ATP. We also found that the presence of ATP attenuated the sensor’s response
to ADP. In the presence of 10 µM ATP, the sensor was still able to detect ADP with similar affinity but
diminished the dynamic range (Figure 6b). At a saturating concentration of 50 µM ATP, the response
to ADP was abolished. These interfering effects of ATP may in part qualitatively explain differences
observed in the cell-based assays and dilute protein solution studies given that we measured a large
change in ATP content upon cyanide treatment of the live bacterial cultures (Figure S1). However, tens
of micromolar concentrations of ATP are thought to be pathologically high for basal fluctuations of
extracellular nucleotides outside the cell. Thus, the sensor’s sensitivity, even in the presence of ATP,
should be sufficient to detect changes in extracellular ADP.
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Figure 6. ATP binding and interference. (a) ATP elicits a fluorescence response with a significantly
lower apparent affinity of Kd = 9.9 ± 6.3 µM in solution studies, maintaining a > 50-fold selectivity for
ADP over ATP. (b) Increasing concentrations of ATP can attenuate the response of the sensor to ADP
(10 mM ATP, Kd = 0.22 ± 0.09 mM; 50 mM ATP, no fit; mean ± std, n = 6).
Outside the cell, adenosine is another possible interfering molecule that could be encountered
during purinergic signaling, but its binding to ParM has not been assessed previously [16,17]. We found
that our ADP sensor exhibited no appreciable affinity for adenosine in its dose-response (Figure 7a).
Furthermore, the presence of even very high concentrations of adenosine did not compromise the
sensor’s response to ADP at all (Figure 7b).Sensors 2019, 19, x FOR PEER REVIEW 10 of 15 
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found that FRET ratio exhibited very similar pKa values of ~6.5 and ~6.3 in the absence or presence of
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ADP, respectively (Figure 8d). This pKa value matches well with the pKa of ~6 for mVenus [24], while
mTFP1 is pH insensitive with a pKa of 4.3 [23]. Given that the ADP affinity is not strongly perturbed
by pH, these observations suggest that the pH sensitivity of the absolute FRET ratio signal is primarily
due to the pH-sensitive mVenus and is not likely due to pH-sensitive nucleotide binding to ParM.
In addition, we observed that the sensor response was stable at pH 7.0 and higher, which would be
well-suited for many extracellular sensing studies in buffered bath solutions.
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Although our protein solution studies revealed that our ADP sensor has a limited dynamic range,
as mentioned, we were encouraged by the successful use of other low dynamic range FRET sensors
in live-cell imaging studies [26,29,30]. In particular, ratiometric imaging could be quite robust and
sensitive because of the intrinsic normalization against artifacts caused by varying expression levels or
other heterogeneities, and thus, we next demonstrated proof-of-concept that our sensor could be used
to detect extracellular ADP in live-cell cultures.
3.4. Cell Surface Expression and Characterization
In order to measure extracellular ADP at the cell surface, we genetically fused the sensor to a
transmembrane anchor derived from the platelet-derived growth factor receptor with an IgK signal
sequence [13]. For convenience, we named this cell surface-targeted construct “ADPrime” (ADP
sensor for Ratiometric IMaging of Extracellular purines). It was clear, even with widefield microscopy,
that ADPrime targeted well to the surface of live HEK293 cells, which showed strong fluorescence
signals at the membrane. To establish that ADPrime responds to extracellular ADP, we subjected the
sensor expressing HEK293 cells to continuous superfusion and washed in a high, near-saturating
concentration of 100 µM ADP, to ensure we would see a visible response. On average, we observed a
dampened response compared to the soluble protein with a 3% increase in FRET ratio, and subsequent
increase to 1 mM ADP by wash-in only increased the FRET ratio to 4% indicating saturation as expected
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(Figure 9). The response was fully reversed upon washout with an imaging solution lacking any ADP.
In other studies, we did not observe robust responses to 1 mM ADP, but we did observe saturation
of the response at 10 mM ADP (Figure S2), indicating that ADPrime exhibits micromolar apparent
affinity when expressed on the surface of live cells. This attenuation in response and decrease in affinity
compared to the sensor’s solution behavior is not entirely unexpected because we observed a very
similar attenuation in the response and affinity of the ATeam sensor when we previously developed a
cell surface-displayed extracellular ATP sensor [13]. We also note that the response to ADP wash in
and wash out had time constants of ~60 s because the apparent on and off-rate kinetics are limited by
our perfusion and mixing system. Furthermore, expression of ADPrime on the cell surface did not
have any overt negative effects on cell viability (Figure S3). Despite the relatively small change in FRET
ratio, the maximum response of 4.4 ± 0.2% (mean ± 95% CI) was highly reproducible across 77 cells
in 11 independent experiments. Given the promising result that ADPrime provides in response to
the exogenous addition of extracellular ADP, we next tested if it could detect a physiological release
of ADP.
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3.5. Detection of Physiological Nucleotide Release 
To demonstrate that ADPrime could detect a physiologically relevant nucleotide release, we 
subjected sensor expressing HEK293 cells to hypoosmotic stress because purinergic signaling is well 
established to play an important role in the volume regulatory response in a broad number of cell 
types [1,7–12]. After measuring a baseline with continuous superfusion of an isotonic imaging 
Figure 9. The ADPrime sensor responds to extracellular ADP. Widefield microscopy shows an example
of a sensor expressing HEK293 cell. Panels show individual (a) differential interference contrast, (b) CFP,
and (c) YFP channels as well as C/Y ratio images (d) before and (e) after ADP wash-in. The false color
calibration bar is for the raw mTFP/FRET ratio. Scale bar = 50 µm. (f) Time course of ADPrime response
on live cells, mean ± 95% CI (77 cells, 11 experiments).
3.5. Detection of Physiological Nucleotide Release
To demonstrate that ADPrime could detect a physiologically relevant nucleotide release, we
subjected sensor expressing HEK293 cells to hypoosmotic stress because purinergic signaling is well
established to play an important role in the volume regulatory response in a broad number of cell
types [1,7–12]. After measuring a baseline with continuous superfusion of an isotonic imaging solution
(~300 mosmol), hypotonic imaging solution (~150 mosmol) was washed in. The hypotonic solution
was reduced by half in sodium chloride concentration but still contained the other buffer and salt
components. This reduction in osmolality caused an immediate increase in the ADPrime FRET
ratio to a maximum response of 3.9 ± 0.8% (mean ± 95% CI, 62 cells, nine experiments), reporting
a release of extracellular nucleotides consistent with previous reports using similar in vitro models
(Figure 10) [7–11]. The ADPrime response could be reversed by washout and return to the isotonic
solution, and we validated that the sensor remained responsive with a subsequent pulse of exogenous
ADP. Nucleotide release can involve the direct secretion of ATP and ADP to the extracellular space, and
extracellular ATP is also quickly converted to ADP by ectonucleotidases such as CD39 [6]. We found
that the sensor also responded to a pulse of exogenous ATP, as expected from our characterization
of the selectivity in protein solution studies. Thus, ADPrime can reproducibly detect a hypoosmotic
shock-induced release of purines, though it is not clear if it is detecting ADP, ATP, or both in this
particular experiment. In this study, we focus on our first generation ADPrime sensor, but in future
studies beyond the scope of this work, ADPrime could be combined with ecATeam [13] to distinguish
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between ADP and ATP species. Regardless, both ADP and ATP are involved in purinergic signaling,
indicating that ADPrime could be used to monitor signaling dynamics.
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4. Discussion
In this study, we developed a genetically encoded fluorescent sensor of extracellular ADP called
ADPrime and demonstrated that it detects the release of extracellular nucleotides from live cells.
One of our major objectives was to show that the E. coli ParM protein could be combined with
fluorescent protein technology to engineer this sensor, building on the work of Kunzelman and
Webb [16,17]. Previously, Kunzelman and Webb used a semisynthetic strategy by conjugating synthetic
dyes to cysteine-mutants of ParM. Their strategy yielded two sensors that exhibit three-fold and 10-fold
maximal responses to ADP binding, and the high dynamic ranges result from the unquenching of the
small organic fluorophores used, making these sensors ideal for solution studies. Clearly, ADPrime
offers a significantly reduced dynamic range compared to these semisynthetic sensors, which is typical
of ratiometric FRET sensors compared to intensity-based turn-on fluorescence sensors. However, FRET
sensors with low dynamic range have still proven to be of great use for live-cell imaging studies because
they are ratiometric, which provides an intrinsically normalized signal that improves quantitative
comparisons across independent trials, and because they are genetically targetable. For example,
the TORCAR FRET sensor exhibited a 13% FRET dynamic range and was effectively used to study
the subcellular distribution of mTORC activity in live cells [26]. In addition, the Laconic [29] and
Pyronic [30] FRET sensors of lactate and pyruvate exhibit 11% and 24% FRET dynamic ranges,
respectively. These sensors have been used successfully to study brain energy metabolism in cultured
cells, brain slices, and in vivo [31,32]. Similarly, we carried out a physiological proof-of-concept and
demonstrated that ADPrime was effective in detecting the hypoosmotic stress-induced release of ADP
and ATP in live-cell imaging studies. In particular, because ADPrime is entirely genetically encoded,
it could be tethered to the cell exterior without the need for any surface chemistry. Thus, our sensor
shows that ParM provides a high-affinity scaffold that is appropriate for the detection of the low
concentrations of extracellular ADP that are involved in purinergic signaling.
As a first-generation extracellular ADP sensor, ADPrime was already able to detect endogenous
purinergic signals. However, we were unable to discriminate between extracellular ATP and ADP with
certainty in our hypoosmotic shock studies despite the 62-fold selectivity for ADP or ATP. It is not clear
why ADPrime exhibits a decrease in nucleotide selectivity compared to other ParM constructs that
show greater selectivity for ADP over ATP. It is possible that steric constraints imposed by the fusion to
the large fluorescent proteins alter the coupled equilibrium between nucleotide binding and the closed
and open states. In future studies during the development of next-generation sensors, a mutational
analysis may shed light on this interesting observation. Regardless of the needed improvements in
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selectivity, ADPrime is the first fully genetically encoded sensor that harbors a sufficiently high affinity
for ADP that matches extracellular levels expected during purinergic signaling.
ADPrime could also be improved by increasing the FRET dynamic range. In particular, we
measured that the mTFP1 donor lifetime in ADPrime is ~1 ns shorter than 3.2 ns lifetime of mTFP1
alone [23], suggesting that ADPrime experiences relatively high FRET in both apo and ADP-bound
states. Thus, it may be fruitful to optimize the change in orientations of the FRET pair through
further optimization of the fluorescent protein linkers [27] and by testing new fluorescent proteins that
have been reported to serve well as high-efficiency FRET pairs [33]. Furthermore, in this study, we
chose a FRET strategy because of the extensive number of examples using this strategy to re-purpose
conformationally dynamic ligand-binding domains into sensors and because ratiometric sensors
intrinsically normalize for expression level when considering live-cell studies [34]. However, we
demonstrated that the ParM scaffold tolerates fusions to fluorescent proteins, and therefore a number
of other sensor architectures, such as those using circularly permuted fluorescent proteins, could be
explored in the future.
Interestingly, we also observed that ADPrime showed a ~0.2 ns change in mTFP1 donor
fluorescence lifetime, which is comparable to other FRET probes, such as recent iterations of the ERK
and PKA sensors that show 0.20–0.25 ns lifetime changes and have been used to study neuronal
signaling dynamics [35]. Although fluorescence lifetime imaging microscopy (FLIM) is beyond the
scope of this study, ADPrime has a lifetime dynamic range that could make it appropriate for live-cell
FLIM studies.
Overall, ADPrime is an important new addition to the purinergic signaling toolkit because sensors
of extracellular ADP had not been available until now. In combination with other sensors such
as ecATeam [13], jrGECO1a [36], and PinkFlamindo [37], for example, ADPrime will be useful for
quantitatively studying both upstream purinergic signal release dynamics and downstream G-protein
Ca2+ and cAMP signaling.
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